DaVita HealthCare Partners Inc (DVA): Berkshire Hathaway Inc. (BRK.A) Won’t Be Buying This Health Care Company After All

Page 2 of 2

In addition, shareholders don’t seem to mind that the company set aside $300 million for the settlement of a U.S. Justice Department investigation into a potential kickback scheme. CEO Kent Thiry did say, however, that a final agreement with the U.S. investigators hasn’t been reached yet, asserting, “We’ve been under the impression for more than a decade that the way we do things is fine, so we’ve had to do a lot of sorting out with them.”

Foolish final thoughts
Of course, it’s a safe bet that few companies would complain about Berkshire Hathaway Inc. (NYSE:BRK.A) standing as their single largest shareholder — and for DaVita HealthCare Partners Inc (NYSE:DVA), that’s a vote of confidence that cannot be overstated. As a result, and as long as they maintain Berkshire’s seal of approval, I won’t be closing my “outperform” CAPScall on the company anytime soon.

The article Berkshire Won’t Be Buying This Health Care Company After All originally appeared on Fool.com and is written by Steve Symington.

Fool contributor Steve Symington has no position in any stocks mentioned. The Motley Fool recommends Berkshire Hathaway and H.J. Heinz Company (NYSE:HNZ) Company. The Motley Fool owns shares of Berkshire Hathaway.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.


Page 2 of 2